Combination of Olaparib and Navitoclax in Women with HGSC and TNBC

Name: Women's Health Trial Tracker
Creator: 1 Women’s Health
License: United States government work; public domain unless the source record says otherwise.

Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.

Records: 5,000
Last changed: 08/26/2026
Update schedule: 55 1 * * * UTC
Coverage: 05/26/2000–08/25/2026
Method: Methodology

Title: Combination of Olaparib and Navitoclax in Women with HGSC and TNBC
Record Date: 05/03/2022
Vuga Group: INTERVENTIONAL
Change Status: unchanged
Recency Days: 1,576.85
Public Significance Score: 0